239 related articles for article (PubMed ID: 16254373)
1. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.
Guo Y; Guo H; Zhang L; Xie H; Zhao X; Wang F; Li Z; Wang Y; Ma S; Tao J; Wang W; Zhou Y; Yang W; Cheng J
J Virol; 2005 Nov; 79(22):14392-403. PubMed ID: 16254373
[TBL] [Abstract][Full Text] [Related]
2. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
3. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.
Ren GL; Fang Y; Ma HH; Lei YF; Wang D; Xu MC; Wang PZ; Huang CX; Nie OH; Sun YT; Bai XF
Antivir Ther; 2007; 12(6):865-76. PubMed ID: 17926641
[TBL] [Abstract][Full Text] [Related]
4. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
5. Application of allele-specific RNAi in hepatitis B virus lamivudine resistance.
Teng X; Liu JY; Li D; Fang Y; Wang XY; Ma YX; Chen SJ; Zhao YX; Xu WZ; Gu HX
J Viral Hepat; 2011 Oct; 18(10):e491-8. PubMed ID: 21914068
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAi.
Teng X; Xu WZ; Hao ML; Fang Y; Zhao YX; Chen SJ; Li D; Gu HX
J Virol Methods; 2010 Sep; 168(1-2):6-12. PubMed ID: 20403386
[TBL] [Abstract][Full Text] [Related]
7. Differentially expressed cellular genes following HBV: potential targets of anti-HBV drugs?
Yang J; Bo XC; Yao J; Yang NM; Wang SQ
J Viral Hepat; 2005 Jul; 12(4):357-63. PubMed ID: 15985005
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
9. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
[TBL] [Abstract][Full Text] [Related]
10. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of HBx mRNA in HepG2.2.15 cells by small interfering RNA.
Jiao J; Cao H; Chen XW; Zhou MJ; Liu ZH; Ding ZH
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1114-8. PubMed ID: 17998838
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery.
Wen WH; Liu JY; Qin WJ; Zhao J; Wang T; Jia LT; Meng YL; Gao H; Xue CF; Jin BQ; Yao LB; Chen SY; Yang AG
Hepatology; 2007 Jul; 46(1):84-94. PubMed ID: 17596868
[TBL] [Abstract][Full Text] [Related]
13. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.
Chen Z; Xu ZF; Ye JJ; Yao HP; Zheng S; Ding JY
J Zhejiang Univ Sci B; 2005 Apr; 6(4):236-41. PubMed ID: 15754419
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
15. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
16. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
[TBL] [Abstract][Full Text] [Related]
17. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
Fu J; Tang ZM; Gao X; Zhao F; Zhong H; Wen MR; Sun X; Song HF; Qian XH
Acta Pharmacol Sin; 2008 Dec; 29(12):1522-8. PubMed ID: 19026173
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line.
Konishi M; Wu CH; Wu GY
Hepatology; 2003 Oct; 38(4):842-50. PubMed ID: 14512871
[TBL] [Abstract][Full Text] [Related]
19. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
20. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]